AZ Crows About Oncology Portfolio In 1Q; Strives For $1.1bn Cost Save

 
• By Lucie Ellis-Taitt

AstraZeneca PLC is restructuring and streamlining its commercial and manufacturing operations under a new cost-cutting effort in order to save $1.1bn annually from 2017 and focus internally on just three core areas.

More from Strategy

More from Business